Recombinant AKT1 anticorps (PH domain)

N° du produit ABIN5671212

L’anticorps anti-AKT1 Monoclonal Lapin est utilisé pour la détection de AKT1 dans des échantillons de Humain. Il a été validé pour WB et IHC.

Aperçu rapide pour Recombinant AKT1 anticorps (PH domain) (ABIN5671212)

Antigène: AKT1 (V-Akt Murine Thymoma Viral Oncogene Homolog 1 (AKT1))

Type d'anticorp: Recombinant Antibody

Reactivité: Humain

Hôte: Lapin

Clonalité: Monoclonal

Conjugué: Cet anticorp AKT1 est non-conjugé

Application: Western Blotting (WB), Immunohistochemistry (IHC)

Clone: RM316

Détail du produit anti-AKT1 anticorps

Épitope: PH domain

Fonction: Rabbit monoclonal to AKT (PH domain)

Specificité: This antibody reacts to human AKT (PH domain). It may also react to mouse or rat AKT, as predicted by immunogen homology.

Purification: Protein A affinity purified from an animal origin-free culture supernatant

Immunogène: A peptide corresponding to the PH domain of human AKT

Isotype: IgG

Information d'application

Indications d'application: Immunohistochemistry (IHC): 1:200-1:500 dilution, WB: 1:5000-1:10000 dilution.

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: 50 % Glycerol/PBS with 1 % BSA and 0.09 % sodium azide

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: -20.0°C

Détails sur AKT1

Antigène: AKT1 (V-Akt Murine Thymoma Viral Oncogene Homolog 1 (AKT1))

Autre désignation: AKT

ID gène: 207

UniProt: P31749

Pathways: Signalisation PI3K-Akt, Signalisation RTK, TCR Signaling, AMPK Signaling, Interferon-gamma Pathway, Signalisation TLR, Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Response to Water Deprivation, Regulation of Actin Filament Polymerization, Carbohydrate Homeostasis, Glycosaminoglycan Metabolic Process, Cellular Glucan Metabolic Process, Regulation of Muscle Cell Differentiation, Cell-Cell Junction Organization, Regulation of Cell Size, Skeletal Muscle Fiber Development, Regulation of Carbohydrate Metabolic Process, Hepatitis C, Protein targeting to Nucleus, CXCR4-mediated Signaling Events, Signaling Events mediated by VEGFR1 and VEGFR2, Negative Regulation of intrinsic apoptotic Signaling, Thromboxane A2 Receptor Signaling, Signaling of Hepatocyte Growth Factor Receptor, Positive Regulation of fat Cell Differentiation, VEGFR1 Specific Signals, VEGF Signaling, L'effet Warburg